title: In reply--Effect of β-adrenergic blockers and other antihypertensive drugs on the risk of melanoma recurrence and death.
authors.affiliation: University Hospital, University of Florence, Florence, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: De Giorgi
authors.affiliation: European Institute of Oncology, Milan, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Gandini
authors.affiliation: University Hospital, University of Florence, Florence, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Grazzini
authors.affiliation: University Hospital, University of Florence, Florence, Italy.
authors.forename: Silvia
authors.initials: S
authors.lastname: Benemei
authors.affiliation: University Hospital, University of Florence, Florence, Italy.
authors.forename: Niccolò
authors.initials: N
authors.lastname: Marchionni
authors.affiliation: University Hospital, University of Florence, Florence, Italy.
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Geppetti
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000401:mortality*; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology*
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents